This is a lecture on the Basic information on Parkinson's Disease. There is also a Video that I have prepared based on this presentation on You Tube Channel - KNOLEAD
www.knolead.com
Parkinson's disease (PD) is a neurodegenerative brain disorder that causes tremors and slow movement. It occurs when dopamine-producing brain cells die, reducing dopamine levels and the ability to control movement. Approximately 60,000 Americans and 15,000-20,000 Malaysians are diagnosed with PD each year. While the exact causes are unknown, genetics and environmental toxins like manganese are contributing factors. Current treatments aim to replace dopamine or slow its breakdown, but there is no cure. Later stages result in greater loss of mobility and potential cognitive issues. Prevention focuses on diet high in antioxidants and vitamins.
The document discusses Parkinson's disease, including its causes, symptoms, stages, diagnosis, treatment, and prevention. Some key points:
- Parkinson's is a progressive nervous system disorder caused by loss of dopamine-producing brain cells. Symptoms include tremors, rigidity, and impaired movement.
- It is staged from 1 to 5 based on severity, from mild symptoms on one side of the body to requiring 24/7 care. Diagnosis is based on symptoms and medical history.
- Treatment focuses on managing symptoms through medications like levodopa and carbidopa that aim to replace dopamine. Surgery like deep brain stimulation may also help in severe cases.
- Risk can be reduced through diet high in omega
The document provides information about Parkinson's disease including:
- Symptoms can include motor symptoms like tremors as well as non-motor symptoms affecting mood, behavior, and cognition.
- Diagnosis is based on medical history and exam, and dopamine levels are reduced in the brain.
- Treatment options include medications to manage symptoms, deep brain stimulation surgery, and therapies like physical, speech, and exercise.
- Risk factors include age and possible environmental toxins, though the exact causes are still being researched. Progression varies between individuals.
This document provides an overview of Parkinson's disease for allied health personnel. It begins with examples of famous individuals who lived with Parkinson's. It then outlines the topics to be covered, which include epidemiology, etiology, clinical presentations, investigations, available treatments, and prognosis. The document discusses the global burden of Parkinson's and prevalence in Asia. It reviews the history of Parkinson's disease and its discovery. Key points covered include the pathologies and causes of Parkinson's, typical motor and non-motor symptoms, diagnostic criteria and scales for assessing severity. Investigations like dopamine transporter scans are mentioned. The document outlines pharmacological and non-pharmacological treatment approaches as well as new therapies like deep brain stimulation. It concludes with statistics
Parkinson's disease is a progressive neurodegenerative disorder that results from the loss of dopamine-producing neurons in the substantia nigra. The main motor symptoms include tremors, rigidity, bradykinesia, and postural instability. Diagnosis is based on the presence of at least two of these cardinal motor symptoms. While there is no cure for PD, medications can help manage symptoms by increasing dopamine levels in the brain. Levodopa combined with carbidopa is very effective but long-term use can cause motor complications like fluctuations and dyskinesia that require adjustment of the treatment regimen.
Parkinson's disease is a neurological disorder that occurs when certain neurons in the brain die or become damaged. These neurons produce dopamine, which is important for muscle movement throughout the body. The main symptoms include tremors, slow movement, stiffness, and balance and walking problems. Currently there is no cure, but medications can help treat symptoms by replacing dopamine. Researchers are working on developing treatments using stem cells to create new dopamine neurons.
Parkinson's disease (PD) is a neurodegenerative brain disorder that causes tremors and slow movement. It occurs when dopamine-producing brain cells die, reducing dopamine levels and the ability to control movement. Approximately 60,000 Americans and 15,000-20,000 Malaysians are diagnosed with PD each year. While the exact causes are unknown, genetics and environmental toxins like manganese are contributing factors. Current treatments aim to replace dopamine or slow its breakdown, but there is no cure. Later stages result in greater loss of mobility and potential cognitive issues. Prevention focuses on diet high in antioxidants and vitamins.
The document discusses Parkinson's disease, including its causes, symptoms, stages, diagnosis, treatment, and prevention. Some key points:
- Parkinson's is a progressive nervous system disorder caused by loss of dopamine-producing brain cells. Symptoms include tremors, rigidity, and impaired movement.
- It is staged from 1 to 5 based on severity, from mild symptoms on one side of the body to requiring 24/7 care. Diagnosis is based on symptoms and medical history.
- Treatment focuses on managing symptoms through medications like levodopa and carbidopa that aim to replace dopamine. Surgery like deep brain stimulation may also help in severe cases.
- Risk can be reduced through diet high in omega
The document provides information about Parkinson's disease including:
- Symptoms can include motor symptoms like tremors as well as non-motor symptoms affecting mood, behavior, and cognition.
- Diagnosis is based on medical history and exam, and dopamine levels are reduced in the brain.
- Treatment options include medications to manage symptoms, deep brain stimulation surgery, and therapies like physical, speech, and exercise.
- Risk factors include age and possible environmental toxins, though the exact causes are still being researched. Progression varies between individuals.
This document provides an overview of Parkinson's disease for allied health personnel. It begins with examples of famous individuals who lived with Parkinson's. It then outlines the topics to be covered, which include epidemiology, etiology, clinical presentations, investigations, available treatments, and prognosis. The document discusses the global burden of Parkinson's and prevalence in Asia. It reviews the history of Parkinson's disease and its discovery. Key points covered include the pathologies and causes of Parkinson's, typical motor and non-motor symptoms, diagnostic criteria and scales for assessing severity. Investigations like dopamine transporter scans are mentioned. The document outlines pharmacological and non-pharmacological treatment approaches as well as new therapies like deep brain stimulation. It concludes with statistics
Parkinson's disease is a progressive neurodegenerative disorder that results from the loss of dopamine-producing neurons in the substantia nigra. The main motor symptoms include tremors, rigidity, bradykinesia, and postural instability. Diagnosis is based on the presence of at least two of these cardinal motor symptoms. While there is no cure for PD, medications can help manage symptoms by increasing dopamine levels in the brain. Levodopa combined with carbidopa is very effective but long-term use can cause motor complications like fluctuations and dyskinesia that require adjustment of the treatment regimen.
Parkinson's disease is a neurological disorder that occurs when certain neurons in the brain die or become damaged. These neurons produce dopamine, which is important for muscle movement throughout the body. The main symptoms include tremors, slow movement, stiffness, and balance and walking problems. Currently there is no cure, but medications can help treat symptoms by replacing dopamine. Researchers are working on developing treatments using stem cells to create new dopamine neurons.
This document discusses the treatment of depression in the elderly. It notes that while healthy older adults are not at greater risk of depression than younger adults, risk factors in the elderly include multiple losses, medical illness, and a history of previous depression. Depression is common in elderly patients with medical conditions like stroke, cancer, and heart disease. Treatment includes addressing any underlying medical causes or drugs that may be contributing, starting with low doses of selective serotonin reuptake inhibitors which have fewer side effects in older patients, and considering psychotherapy, electroconvulsive therapy, or mood stabilizers if needed. Close monitoring for side effects and compliance is important when medicating elderly patients.
Parkinson's disease is caused by a lack of dopamine in the brain. While the exact cause is unknown, genetic and environmental factors may play a role. Symptoms include slow movement, stiffness, tremors, poor posture, fatigue, and depression. There is no cure, but treatment focuses on managing symptoms through medication and therapies. Exercise and physical therapy can help maintain strength, mobility, and independence for those living with Parkinson's.
A 64-year-old woman presented with complaints of forgetfulness, difficulty cooking and managing household tasks, and inability to identify relatives over the past year. Neurological examination and investigations revealed no abnormalities except a low score on the Montreal cognitive assessment. This document defines dementia, discusses its causes and types, presents assessment tools and management strategies, and emphasizes the importance of a multidisciplinary approach and caregiver support.
Parkinson's Disease, SYMPTOMS OF PARKINSONISM, STAGES OF PARKINSONISM, ETIOLOGY OF PARKINSONISM, PATHOPHYSIOLOGY OF PARKINSONISM, TREATMENT OF PARKINSONISM.
Parkinson's disease is a degenerative disorder of the central nervous system that affects movement. It occurs when nerve cells in the brain do not produce enough dopamine. The document outlines the symptoms, stages, causes, treatment, and animal models of Parkinson's disease. The main symptoms are motor symptoms like tremors and rigidity as well as non-motor symptoms like mood changes. Treatment focuses on replacing dopamine and managing symptoms, primarily using levodopa and dopamine agonists. Animal models aim to reproduce the features of Parkinson's through pharmacological or genetic means to better understand and research the disease.
'Parkinson's Disease Service in Cumbria' - Dr Jim George (Consultant Physician for North Cumbria University Trust) from the Cumbria Neuroscience Conference
This document discusses scaling up care for mental, neurological, and substance use disorders globally. It aims to close the gap between needed and available care by increasing financial and human resources allocated to these issues, especially in low and middle income countries. It then provides details on schizophrenia, including prevalence, economic burden, increased mortality risks from physical health issues, positive and negative symptoms, treatment approaches including medications and their side effects.
- Parkinson's disease is a degenerative disorder of the basal ganglia affecting movement. It is caused by the loss of dopamine-producing neurons in the substantia nigra.
- The classical symptoms are tremor, rigidity, and bradykinesia. Levodopa combined with a peripheral dopa decarboxylase inhibitor is the main treatment, improving bradykinesia and rigidity but unpredictably helping tremor.
- Long term levodopa use can cause involuntary movements as side effects, though treatment aims to maintain steady dopamine levels in the brain. Anticholinergics, dopamine agonists, MAO-B inhibitors, and amantadine are also used to manage
A 60-year old diabetic male presented with progressive walking difficulty over 1 year and slurred speech for 10 months. Examination found masked face, mild cognitive impairment, spastic dysarthria, vertical gaze palsy, and unstable broad-based gait. MRI showed atrophy of the dorsal midbrain. He was diagnosed with progressive supranuclear palsy and diabetes. Treatment included medications, physiotherapy, and speech therapy, with some improvement in instability and falls over 2 months.
Parkinson's disease is a progressive neurological disorder characterized by bradykinesia and other motor symptoms like rigidity, tremor, and impaired balance. It results from the loss of dopamine-producing neurons in the substantia nigra. The average age of onset is 60, and it is more common in men. While motor symptoms are prominent, non-motor symptoms like cognitive impairment and mood issues become predominant as the disease progresses. Levodopa remains the most effective treatment but can cause side effects, so other drugs and therapies are also used to manage symptoms of Parkinson's disease.
Parkinson's disease is a progressive nervous system disorder that causes tremors, decreased muscle movement, and impaired balance. It occurs when dopamine-generating cells in the brain die, causing low dopamine levels. While the exact cause is unknown, genetic and environmental factors may play a role. Symptoms typically begin on one side of the body and include tremors, slowed movement, muscle stiffness, balance issues, and loss of automatic movements. Diagnosis is based on medical history, symptoms, and tests to rule out other conditions. There is no cure, but treatments aim to reduce symptoms and may include medication, deep brain stimulation surgery, exercise, and healthy eating. Managing the condition requires finding the right doctors, medication management, physical therapy,
Parkinson's disease is a chronic, progressive neurological disorder characterized by rigidity, bradykinesia, tremor, and postural instability. It is caused by the loss of dopamine-producing neurons in the substantia nigra. As the disease progresses, motor symptoms worsen and include freezing of gait, impaired balance, and dementia. There is currently no cure for Parkinson's disease, and treatment aims to manage symptoms through medication and other therapies.
Progressive supranuclear palsy and multiple system atrophySooraj Patil
This document provides an overview of Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA). It defines PSP and MSA as neurodegenerative diseases characterized by selective neuronal dysfunction and loss associated with pathologically altered proteins. The document discusses the pathophysiology, clinical features, subtypes, diagnostic criteria and investigations for PSP and MSA. Key points include that PSP is the second most common cause of parkinsonism after IPD, and involves characteristic tau protein deposits in the brain. Clinical features of PSP include early falls, vertical gaze palsy, speech and swallowing problems, and frontal cognitive deficits. The MDS criteria aim to improve diagnosis of early and variant
Parkinson's disease is a progressive neurodegenerative disorder caused by the death or impairment of nerve cells in the substantia nigra. This results in a loss of dopamine production and motor symptoms like tremors, bradykinesia, rigidity, and postural instability. The disease was first described in 1817 and is most common in older adults over age 60, though early-onset cases under 40 can occur. Treatment involves dopamine replacement therapy with levodopa as well as other drugs and therapies like deep brain stimulation. Ayurveda correlates it with Kampavata and treats it with therapies to increase strength and nourishment like abhyanga, swedana, and shirobasti along with herbs like
Brief overview of hypokinetic movement disorderAhmad Shahir
This document provides an overview of hypokinetic movement disorders, specifically focusing on Parkinson's disease. It defines hypokinetic movements as abnormal movements involving initiation, implementation, velocity, frequency or posture. It then discusses Parkinson's disease in more detail, covering its epidemiology, aetiology, clinical presentations, investigations, available treatments, and prognosis. Key points include that Parkinson's disease is the second most common neurodegenerative disorder, involves the loss of dopaminergic neurons, and can be diagnosed clinically. Treatment involves pharmacological therapies like levodopa as well as non-pharmacological options such as deep brain stimulation for advanced cases.
Hypokinetic Movement Disorders.pptx by dineshdineshdandia
1. Hypokinetic disorders involve a decrease in the normal amount, speed, or amplitude of movement. Bradykinesia specifically refers to slowness of movement, while akinesia is a severe reduction in movement.
2. Parkinson's disease commonly starts around age 60 but can begin earlier, and family history and certain genetic mutations or toxic exposures may play a role in its development.
3. Physical examination of Parkinson's disease patients may reveal features like tremors, rigidity, impaired movement initiation, and changes in gait, posture, and motor functioning.
1. Dementia is a growing problem worldwide, affecting over 47 million people in 2015 and projected to increase significantly by 2050 as populations age.
2. Dementia involves the deterioration of cognitive abilities such as memory, judgment, and problem solving that impair daily living. It can be caused by neurodegenerative, vascular, or other medical conditions.
3. Assessing dementia involves evaluating memory impairment, ruling out other causes like depression, and using screening tools such as the MMSE alongside medical exams and tests to determine severity and guide further evaluation.
This document discusses the treatment of depression in the elderly. It notes that while healthy older adults are not at greater risk of depression than younger adults, risk factors in the elderly include multiple losses, medical illness, and a history of previous depression. Depression is common in elderly patients with medical conditions like stroke, cancer, and heart disease. Treatment includes addressing any underlying medical causes or drugs that may be contributing, starting with low doses of selective serotonin reuptake inhibitors which have fewer side effects in older patients, and considering psychotherapy, electroconvulsive therapy, or mood stabilizers if needed. Close monitoring for side effects and compliance is important when medicating elderly patients.
Parkinson's disease is caused by a lack of dopamine in the brain. While the exact cause is unknown, genetic and environmental factors may play a role. Symptoms include slow movement, stiffness, tremors, poor posture, fatigue, and depression. There is no cure, but treatment focuses on managing symptoms through medication and therapies. Exercise and physical therapy can help maintain strength, mobility, and independence for those living with Parkinson's.
A 64-year-old woman presented with complaints of forgetfulness, difficulty cooking and managing household tasks, and inability to identify relatives over the past year. Neurological examination and investigations revealed no abnormalities except a low score on the Montreal cognitive assessment. This document defines dementia, discusses its causes and types, presents assessment tools and management strategies, and emphasizes the importance of a multidisciplinary approach and caregiver support.
Parkinson's Disease, SYMPTOMS OF PARKINSONISM, STAGES OF PARKINSONISM, ETIOLOGY OF PARKINSONISM, PATHOPHYSIOLOGY OF PARKINSONISM, TREATMENT OF PARKINSONISM.
Parkinson's disease is a degenerative disorder of the central nervous system that affects movement. It occurs when nerve cells in the brain do not produce enough dopamine. The document outlines the symptoms, stages, causes, treatment, and animal models of Parkinson's disease. The main symptoms are motor symptoms like tremors and rigidity as well as non-motor symptoms like mood changes. Treatment focuses on replacing dopamine and managing symptoms, primarily using levodopa and dopamine agonists. Animal models aim to reproduce the features of Parkinson's through pharmacological or genetic means to better understand and research the disease.
'Parkinson's Disease Service in Cumbria' - Dr Jim George (Consultant Physician for North Cumbria University Trust) from the Cumbria Neuroscience Conference
This document discusses scaling up care for mental, neurological, and substance use disorders globally. It aims to close the gap between needed and available care by increasing financial and human resources allocated to these issues, especially in low and middle income countries. It then provides details on schizophrenia, including prevalence, economic burden, increased mortality risks from physical health issues, positive and negative symptoms, treatment approaches including medications and their side effects.
- Parkinson's disease is a degenerative disorder of the basal ganglia affecting movement. It is caused by the loss of dopamine-producing neurons in the substantia nigra.
- The classical symptoms are tremor, rigidity, and bradykinesia. Levodopa combined with a peripheral dopa decarboxylase inhibitor is the main treatment, improving bradykinesia and rigidity but unpredictably helping tremor.
- Long term levodopa use can cause involuntary movements as side effects, though treatment aims to maintain steady dopamine levels in the brain. Anticholinergics, dopamine agonists, MAO-B inhibitors, and amantadine are also used to manage
A 60-year old diabetic male presented with progressive walking difficulty over 1 year and slurred speech for 10 months. Examination found masked face, mild cognitive impairment, spastic dysarthria, vertical gaze palsy, and unstable broad-based gait. MRI showed atrophy of the dorsal midbrain. He was diagnosed with progressive supranuclear palsy and diabetes. Treatment included medications, physiotherapy, and speech therapy, with some improvement in instability and falls over 2 months.
Parkinson's disease is a progressive neurological disorder characterized by bradykinesia and other motor symptoms like rigidity, tremor, and impaired balance. It results from the loss of dopamine-producing neurons in the substantia nigra. The average age of onset is 60, and it is more common in men. While motor symptoms are prominent, non-motor symptoms like cognitive impairment and mood issues become predominant as the disease progresses. Levodopa remains the most effective treatment but can cause side effects, so other drugs and therapies are also used to manage symptoms of Parkinson's disease.
Parkinson's disease is a progressive nervous system disorder that causes tremors, decreased muscle movement, and impaired balance. It occurs when dopamine-generating cells in the brain die, causing low dopamine levels. While the exact cause is unknown, genetic and environmental factors may play a role. Symptoms typically begin on one side of the body and include tremors, slowed movement, muscle stiffness, balance issues, and loss of automatic movements. Diagnosis is based on medical history, symptoms, and tests to rule out other conditions. There is no cure, but treatments aim to reduce symptoms and may include medication, deep brain stimulation surgery, exercise, and healthy eating. Managing the condition requires finding the right doctors, medication management, physical therapy,
Parkinson's disease is a chronic, progressive neurological disorder characterized by rigidity, bradykinesia, tremor, and postural instability. It is caused by the loss of dopamine-producing neurons in the substantia nigra. As the disease progresses, motor symptoms worsen and include freezing of gait, impaired balance, and dementia. There is currently no cure for Parkinson's disease, and treatment aims to manage symptoms through medication and other therapies.
Progressive supranuclear palsy and multiple system atrophySooraj Patil
This document provides an overview of Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA). It defines PSP and MSA as neurodegenerative diseases characterized by selective neuronal dysfunction and loss associated with pathologically altered proteins. The document discusses the pathophysiology, clinical features, subtypes, diagnostic criteria and investigations for PSP and MSA. Key points include that PSP is the second most common cause of parkinsonism after IPD, and involves characteristic tau protein deposits in the brain. Clinical features of PSP include early falls, vertical gaze palsy, speech and swallowing problems, and frontal cognitive deficits. The MDS criteria aim to improve diagnosis of early and variant
Parkinson's disease is a progressive neurodegenerative disorder caused by the death or impairment of nerve cells in the substantia nigra. This results in a loss of dopamine production and motor symptoms like tremors, bradykinesia, rigidity, and postural instability. The disease was first described in 1817 and is most common in older adults over age 60, though early-onset cases under 40 can occur. Treatment involves dopamine replacement therapy with levodopa as well as other drugs and therapies like deep brain stimulation. Ayurveda correlates it with Kampavata and treats it with therapies to increase strength and nourishment like abhyanga, swedana, and shirobasti along with herbs like
Brief overview of hypokinetic movement disorderAhmad Shahir
This document provides an overview of hypokinetic movement disorders, specifically focusing on Parkinson's disease. It defines hypokinetic movements as abnormal movements involving initiation, implementation, velocity, frequency or posture. It then discusses Parkinson's disease in more detail, covering its epidemiology, aetiology, clinical presentations, investigations, available treatments, and prognosis. Key points include that Parkinson's disease is the second most common neurodegenerative disorder, involves the loss of dopaminergic neurons, and can be diagnosed clinically. Treatment involves pharmacological therapies like levodopa as well as non-pharmacological options such as deep brain stimulation for advanced cases.
Hypokinetic Movement Disorders.pptx by dineshdineshdandia
1. Hypokinetic disorders involve a decrease in the normal amount, speed, or amplitude of movement. Bradykinesia specifically refers to slowness of movement, while akinesia is a severe reduction in movement.
2. Parkinson's disease commonly starts around age 60 but can begin earlier, and family history and certain genetic mutations or toxic exposures may play a role in its development.
3. Physical examination of Parkinson's disease patients may reveal features like tremors, rigidity, impaired movement initiation, and changes in gait, posture, and motor functioning.
1. Dementia is a growing problem worldwide, affecting over 47 million people in 2015 and projected to increase significantly by 2050 as populations age.
2. Dementia involves the deterioration of cognitive abilities such as memory, judgment, and problem solving that impair daily living. It can be caused by neurodegenerative, vascular, or other medical conditions.
3. Assessing dementia involves evaluating memory impairment, ruling out other causes like depression, and using screening tools such as the MMSE alongside medical exams and tests to determine severity and guide further evaluation.
Similar to Parkinson's Disease Patient Lecture - by Dr Sweta Singla (20)
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
2. Why do we need to
understand About
Parkinson’s Disease
WHO Global Estimates : More than 8.5 million people worldwide are
living with PD.
The Prevalence of PD has doubled
in the past 25 years
3. Elderly Indians has increased from 5.6% (51 million) in 1961 to
7.1% (71million) in 2001.
0.
2.
4.
6.
8.
1961 2001
4. Parkinson’s disease is the commonest
movement disorder ( 24 % )
24%
76%
3-8 % of Neurological disorders
• 20 % of neurology admissions
• 33 % of residents of old age
home
Movement Disorders
5. Affects Quality of Life of Patients and Care givers
Informal carers (i.e. most commonly family members and
friends) spend many hours daily providing care for people
living with PD. This can be overwhelming. Physical, emotional
and financial pressures can cause great stress to families and
carers, and support is required from the health, social,
financial and legal systems.
15. PD and PD Plus
❖ Not All patient who are Slow are Parkinson’s Disease
❖ MIMICS of PD : PD Plus syndromes
❖ Progressive Supranuclear Palsy
❖ Secondary Parkinsonism
❖ Multi System Atrophy
❖ Cortico Basal Ganglionic Degeneration
❖ Essential Tremors
❖ Other Diseases where there might be confusion : Depression /
Balance disorders / Arthritis / Hypothyroidism
16. Myths
❖ Genetic Myths - Parkinson’s Disease is heritable - only 4 % of
PD patients are familial
❖ All tremors are PD
❖ No tt for PD
❖ Terminal illness
❖ PD patients should stop working
❖ PD patients can not live independently
❖ PD Patients can not live productive life
17. Myths
❖ PD patient has memory loss
❖ Treating doctors can predict the future
❖ Relationship with other diseases : If Person has PD
explains every other symptoms
❖ PD is not responsible for every problem
18. Points to be noted
❖ PD can not be permanently cured
❖ Management should be started as soon as possible
❖ Dopamine cannot improve all the symptoms
❖ Levodopa Phobia should be avoided - It is a tool for us
- ? should be delayed / dangerous / damages brain
❖ Levo Dopa - only works for few years ?
19. Do not get trapped !
❖ Should defer next dose of LD
❖ Stem cell - no definitive evidence
❖ Apomorphine video - faster action / but injectable /
expensive
❖ Physiotherapy / Physical activity - should always be
done
20. Myths about Sx
❖ DBS - cure / Dangerous
❖ Misinformation
❖ Creating awareness about the PD
❖ Education patient/ care givers / Employers need to be
Educated About PD
❖ Team Work Should be emphasised
22. PD symptoms
❖ Complex
❖ Variale
❖ Pattern / phenomenology
❖ Diagnosis may need review after sometime
23. Akinesia /Bradykinesia
❖ Amplitude and speed
❖ Progressive reduction in the amplitude and speed at different joints
❖ 64 movement or repetitions
❖ micrographia
❖ D/D :
❖ Depression - hypomimia ;
❖ Dystonia may lead to decreased arm swing
❖ Gait problems - also seen in arthritis
24. Tremors
❖ Resting / pill rolling / Remergent termors
❖ D/D : Essential tremors - make a spiral
❖ Drug induced tremors - Hyperthyroid / Beta Agonists -
Asthma Medicines
25. Subtypes of Parkinson’s
Disease
❖ Tremor Predominant
❖ Postural Instability Gait Disorder
❖ PDD - Parkinson’s Disease with Dementia
❖ PD with prominent Non Motor Symptoms
27. Red Flags
❖ Rapid Progression to wheel chair in 5 yr
❖ Early autonomic failure in 5
❖ Early bulbar function in 5 yr
❖ Symm parkinsonism
❖ Absence of non motor symptoms
❖ Pyramidal signs
❖ Early and Reccurent falls
❖ Retrocollis - Trunk bent backwards
29. Management
❖ Non Pharmacological
❖ Pharmacological : Medicines that work on Dopamine
Pathway
❖ Surgery - DBS - Deep Brain Stimulation
❖ Stem Cell/ Gene Therapy - not an option as of now
30. Take Aways
❖ Learn to look for Symptoms of Parkinson’s Disease
around you
❖ Send the patient to a Neurologist so that Diagnosis is
confirmed
❖ Management should be started as soon as possible
❖ Surgery is option is selected cases
❖ Physical Activity should be emphasised in all cases
31. It is Your Life !
&
You need to make sure,
You live it to the full…